Pharmaceuticals, Biotechnology and Life Sciences
Type 1 diabetes decision support technology analyzes patient data from variety of devices to determine insulin delivery recommendations for maintaining…
SAN DIEGO–(BUSINESS WIRE)–Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 3, 2019 the Compensation Committee of…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 3, 2019 the Compensation Committee of…
LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has completed patient enrollment of an open label…
LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has completed patient enrollment of an open label…
Wednesday programming will feature timely discussions on diversity, inclusion and R&D investment PHILADELPHIA–(BUSINESS WIRE)–The 2019 BIO International Convention, the premier…
Wednesday programming will feature timely discussions on diversity, inclusion and R&D investment PHILADELPHIA–(BUSINESS WIRE)–The 2019 BIO International Convention, the premier…
—RVT-802, a one-time therapy, leverages Enzyvant’s T cell generation platform designed to treat profound immunodeficiencies— —Left untreated, congenital athymia is…
—RVT-802, a one-time therapy, leverages Enzyvant’s T cell generation platform designed to treat profound immunodeficiencies— —Left untreated, congenital athymia is…